Viridian (VIRI) | Stock Overview & Key Data
Viridian Therapeutics, Inc. | Mid-cap | Energy
Viridian Therapeutics, Inc. | Mid-cap | Energy
Viridian Performance Comparison
Stock Range
Today's Range
Low: €49.12
High: €50.10
on August 8, 2025
52 Week Range
Low: €31.84
High: €78.73
on October 15, 2024
on March 26, 2025
All-Time High: €6,721.79 on December 1, 2014
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€350.1M
EPS
1.18
P/E Ratio (TTM)
41.32
Forward P/E
4.64
P/B Ratio
0.34
PEG Ratio
4.64
Div. Yield
N/A
ROE
-0.33%
Beta
1.376
Debt to Equity
108.09
Financial Highlights
Profitability
Gross Margin
33.62%
Operating Margin
6.19%
Profit Margin
-0.36%
Returns and Earnings
Return on Assets (TTM)
4.18%
Return on Equity (TTM)
-0.33%
EBITDA
€257.1M
Net Income (TTM)
€-4.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€136.99
Quarterly Revenue Growth (YoY)
-26.10%
Quarterly Earnings Growth (YoY)
-84.10%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Viridian VIRI | 350.11M Mid-cap | -15.48% | -20.32% | -3.31% | -10.23% | -11.98% | 41.39% | -40.55% | -36.43% |
| Technip Energies TE | 6.85B Large-cap | 5.81% | 11.58% | 34.14% | 44.17% | 54.75% | 94.21% | 221.15% | 227.42% |
| Gaztransport Et GTT | 6.25B Large-cap | -0.85% | 0.00% | 11.60% | 13.06% | 21.64% | 29.64% | 24.60% | 100.24% |
| CGG SA CGG | 384.66M Small-cap | -15.48% | -20.32% | -3.31% | -10.23% | -11.98% | 31.94% | 5,441.57% | 5,842.17% |
| Dolfines S.A ALDOL | 4.60M Small-cap | 6.29% | -18.42% | -34.97% | -43.81% | 24.00% | -53.50% | -99.38% | -99.94% |
| TotalEnergies SE TTE | 113.93B Large-cap | 0.69% | 1.14% | 3.21% | -11.04% | -2.51% | -14.43% | 1.10% | 56.72% |
Ownership & Short Interest
Insider Ownership
6.20%
Institutional Ownership
27.04%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
56K
Average 90-Day Volume
41K
Viridian Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Viridian would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is VIRI's 52-week high and low?
- In the last 52 weeks, Viridian reached a high of €78.73 (on March 26, 2025) and a low of €31.84 (on October 15, 2024).
- What is the market cap and P/E ratio for VIRI?
- Curious about Viridian's size and valuation? Its market capitalization stands at 350.11M. When it comes to valuation, the P/E ratio (trailing twelve months) is 41.32, and the forward P/E (looking ahead) is 4.64.
- Does VIRI pay dividends? If so, what's the yield?
- As for dividends, Viridian isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Viridian's main competitors or similar companies to consider before investing?
When looking at Viridian, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Technip Energies
TE6.85B Energy Oil & Gas Equipment & Services 94.21% 221.15% Gaztransport Et
GTT6.25B Energy Oil & Gas Equipment & Services 29.64% 24.60% CGG SA
CGG384.66M Energy Oil & Gas Equipment & Services 31.94% 5,441.57% Dolfines S.A
ALDOL4.60M Energy Oil & Gas Equipment & Services -53.50% -99.38% TotalEnergies SE
TTE113.93B Energy Oil & Gas Integrated -14.43% 1.10% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Viridian Therapeutics, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Viridian's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -0.33%, the Debt to Equity ratio from the most recent quarter is 108.09, and its Gross Profit Margin stands at 33.62%.
- What is the recent revenue and earnings growth for VIRI?
- Looking at Viridian's growth, its revenue over the trailing twelve months (TTM) was €981M. Compared to the same quarter last year (YoY), quarterly revenue grew by -26.10%, and quarterly earnings saw a YoY growth of -84.10%.
- How much of VIRI stock is held by insiders and institutions?
- Wondering who owns Viridian stock? Company insiders (like executives and directors) hold about 6.20% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 27.04%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.